Mutations in TP53, TET2, IDH1, IDH2, DNMT3A, EZH2, ASXL1, and ROBO1/2 were considered as progression‐related drivers in MDS.29, 38, 39. This evidence concerns the gene EZH2 and myelodysplastic syndrome.